CT1 0.00% 1.7¢ ccp technologies limited

for johnmcconks - a bit more

  1. ds
    7,132 Posts.
    take a look at a chart of MBP to see what will probably happen to AGX over the nex couple of weeks. I think we will se it settle into an 80-95c range for a couple of weeks but I do think we will clear $1 around the end of the year (Mid Nov-mid Feb).

    I think we will see $1- $1.30 around the start of the Phase II trials (Mid Jan to Mid April) and from there it depends on the results. If the can clearly show Pulmonary Emboli on the lungs it should be $1.50 - $2. If they take it further and find abdominal PE's etc you might see the FDA fast tracking the product and that should see $2-3. At the Phase III time I believe $2.50-$5 will be the range as success should spell net profit for AGX of A$50m-$120m ongoing. Using $50m and a P/E (price earings) of 15x you get $4.87. By the time Phase III comes about we should be forcasting 10% of the imaging market which should net AGX about $120m or a share price of $11.69. As no one would take that number seriously I stick with predictions of $4.87 for now.
 
watchlist Created with Sketch. Add CT1 (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.00(0.00%)
Mkt cap $6.966M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 166592 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 291257 2
Last update - 16.12pm 22/10/2018 (20 minute delay) ?
CT1 (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.